Eculizumab in STEC-HUS: a paradigm shift in the management of pediatric patients with neurological involvement

ConclusionWe present a case series of four children with STEC-HUS and CNS involvement, managed with eculizumab only, in lieu of plasma exchange (as per our previous policy). The marked improvement in symptoms in our cohort supports the use of eculizumab, rather than plasma exchange in the CNS involvement of STEC-HUS.
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research